Skip to main content
OpenTrials

Clinical trial condition

Rheumatic Diseases

Explore clinical trials studying Rheumatic Diseases. Study availability and eligibility vary by location and protocol.

8,083 public trials 949 recruiting studies
Refine in advanced search Browse all conditions

Rheumatic Diseases trial results

Completed

Co-Administration Of Methotrexate And CP-690,550

NCT01745055

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Pfizer Investigational Site Daytona Beach, Florida, United States
  • Pfizer Investigational Site Fort Lauderdale, Florida, United States
  • Pfizer Investigational Site Miramar, Florida, United States
  • Pfizer Investigational Site Dallas, Texas, United States
View Trial Details
Completed

A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)

NCT00520572

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Research Site Aventura, Florida, United States
  • Research Site Orlando, Florida, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Tampa, Florida, United States
View all 51 locations
View Trial Details
Completed

Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan

NCT00603512

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +6 more
Locations
  • Pfizer Investigational Site Chiba, Japan
  • Pfizer Investigational Site Fukuoka, Japan
  • Pfizer Investigational Site Hitachi-shi, Ibaraki, Japan
  • Pfizer Investigational Site Sagamihara, Kanagawa, Japan
View all 18 locations
View Trial Details
Completed

Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis

NCT01262118

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Pfizer Investigational Site Anniston, Alabama, United States
  • Pfizer Investigational Site Anniston, Alabama, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View Trial Details

Related conditions